tiprankstipranks
Trending News
More News >
Cognition Therapeutics Reports Q1 2025 Financials and Progress
PremiumCompany AnnouncementsCognition Therapeutics Reports Q1 2025 Financials and Progress
29d ago
Cognition Therapeutics reports results from Phase 2 COG2201 trial
Premium
The Fly
Cognition Therapeutics reports results from Phase 2 COG2201 trial
1M ago
Cognition Therapeutics Announces Positive Phase 2 Trial Results
Premium
Company Announcements
Cognition Therapeutics Announces Positive Phase 2 Trial Results
1M ago
Cognition Therapeutics price target lowered to $5 from $6 at H.C. Wainwright
PremiumThe FlyCognition Therapeutics price target lowered to $5 from $6 at H.C. Wainwright
3M ago
Cognition Therapeutics Earnings Call: Progress Amid Challenges
Premium
Company Announcements
Cognition Therapeutics Earnings Call: Progress Amid Challenges
3M ago
Cognition Therapeutics price target lowered to $8 from $11 at Chardan
Premium
The Fly
Cognition Therapeutics price target lowered to $8 from $11 at Chardan
3M ago
Cognition Therapeutics publishes research on zervimesine in dry AMD
PremiumThe FlyCognition Therapeutics publishes research on zervimesine in dry AMD
3M ago
Cognition Therapeutics passes pre-defined futility analysis of Phase 2 study
Premium
The Fly
Cognition Therapeutics passes pre-defined futility analysis of Phase 2 study
3M ago
Cognition VP co-hosting workshop at Neuroimmunology Drug Development Summit
Premium
The Fly
Cognition VP co-hosting workshop at Neuroimmunology Drug Development Summit
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100